June 16, 2020 / 6:24 AM / 22 days ago

BRIEF-Mereo Biopharma Group FY Loss After Tax £35.3 Mln

June 16 (Reuters) - Mereo BioPharma Group plc:

* MEREO BIOPHARMA GROUP PLC - LOSS AFTER TAX FOR 12-MONTH PERIOD OF £35.3 MILLION (2018: £32.0 MILLION)

* MEREO BIOPHARMA GROUP PLC - NET CASH USED IN OPERATING ACTIVITIES FOR YEAR ENDED DECEMBER 31, 2019 OF £45.9 MILLION

* MEREO BIOPHARMA GROUP PLC - IMPACT COVID-19 IS EVOLVING RAPIDLY AND ITS FUTURE EFFECTS ARE UNCERTAIN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below